Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- Two positive phase III studies of tafenoquine for the radical cure of Plasmodium vivax malaria published in The New England Journal of Medicine
- GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture
- GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
Tweets from GSK
-
GSK @GSK
Meet Justin, a GSK doctor and scientific author, who pressed ahead to find the first new treatment for relapsing #malaria in over 60 years #BehindTheScience @MedsforMalaria
about 8 hours ago -
GSK @GSK
Delighted that @NEJM has published ground-breaking data on the first new medicine in over 60 years for relapsing #malaria
about 10 hours ago -
GSK @GSK
#NEWS: This week marks another step closer to eradicating #malaria. Results from two studies of our medicine for relapsing malaria have been published in a prestigious scientific journal @NEJM
about 11 hours ago
